Organon Completes Spin-Out From Merck With Five Biosimilars

Adalimumab Recently Launched In Australia And Canada

Spinning top
Organon biosimilars sales were roughly $330m last year • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products